Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.
This app estimates the probability of a Non–muscle Invasive Bladder Cancer (NMIBC) patient’s progression to MIBC after trans-urethral resection of bladder tumours (TURBT) and calculates their updated European Association of Urology (EAU) Prognostic Factor Risk Group. It Incorporates both the WHO 2004/2016 and WHO 1973 Grading Classification Systems and is based on the following publication: Sylvester RJ, et al. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. Eur Urol (2021),https://doi.org/10.1016/j.eururo.2020.12.033 It is a tool that can be used to help inform treatment decisions, but it does not provide professional advice and it can never replace clinical expertise. Treatment decisions for individual patients should take into account not only clinical expertise, but also patient personal values and their preferences. This calculator has been developed by Ydeal for the EAU. Its developers and its distributors assume no responsibility for the accuracy of the results that are provided or for possible flaws in the system. Nor are they liable for special, direct, indirect or consequential damages, charges, claims, costs, demands, losses, fees or expenses of any nature or kind arising from use of the system. Comments, suggestions and any errors that are found should be sent to info@nmibc.net © European Association of Urology By using the system, the User agrees to these conditions and to abide by international copyright laws and all other applicable laws involving copyright.
